Skip to content

ResMed RMD Sleep And Breathing Health — Selling, general, and administrative

Other segment segments

Residential Care Software
$35.56M+2.4%

Similar metrics at other companies

AdaptHealth logo
AHCOSleep Health — Other operating expenses
$41.06M+25.2%
AdaptHealth logo
AHCOSleep Health — Other segment item
$37.73M+21.7%
Ashland logo
ASHLife Sciences — Selling General And Administrative Expense
$20M+5.3%
Ashland logo
ASHPersonal Care And Household — Selling General And Administrative Expense
$21M0.0%
International Flavors & Fragrances logo
IFFHealth & Biosciences — Selling and administrative expenses
$92M+13.6%
Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Selling, general and administrative expenses
$496M+6.0%

Other financials

Income statement

See full
Revenue$1.4B+10.8%
Gross profit$891.0M+16.3%
Operating income$499.8M+17.3%
Net income$398.7M+9.2%
EPS (diluted)$2.74+10.5%

Balance sheet

See full
Cash & equivalents$1.7B+78.0%
Total debt$1.1B+29.8%
Total equity$6.5B+17.1%
Total assets$8.8B+16.1%

Cash flow

See full
Operating cash flow$554.1M-4.2%
CapEx$33.7M+61.8%
Free cash flow$520.5M-6.7%

Valuation

See full
Market cap$29.05B-22.6%
Enterprise value$28.5B-23.3%
P/E19.1×-7.7×
P/S5.3×-2.0×

Profitability

See full
Gross margin61.6%+2.8pp
Operating margin34.2%+2.1pp
Net margin27.4%+1.3pp
FCF margin31.7%+0.4pp

Returns & leverage

See full
Return on equity25.2%-0.6pp
Debt / equity0.2×0.0×
Current ratio-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's sleep and breathing health — selling, general, and administrative.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ResMed's sleep and breathing health — selling, general, and administrative?
ResMed (RMD) reported sleep and breathing health — selling, general, and administrative of $149.51M in Q1 2026.
How has ResMed's sleep and breathing health — selling, general, and administrative changed year-over-year?
ResMed's sleep and breathing health — selling, general, and administrative increased by 23.0% year-over-year, from $121.56M to $149.51M.
What is the long-term trend for ResMed's sleep and breathing health — selling, general, and administrative?
Over 2 years (2023 to 2025), ResMed's sleep and breathing health — selling, general, and administrative has grown at a 5.3% compound annual growth rate (CAGR), from $443.47M to $491.59M.
What does sleep and breathing health — selling, general, and administrative mean?
Captures the indirect operating expenses required to support the Sleep and Breathing Health segment, including sales force compensation, marketing, and administrative overhead. These costs reflect the investment in market penetration and operational infrastructure for the segment. Monitoring this helps evaluate the scalability of the business model.